Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP) is a multifunctional, primarily mitochondrial matrix protein that forms a homotrimeric, doughnut-shaped structure and is involved in diverse cellular processes. C1QBP inhibits complement C1 activation by binding the globular heads of C1q; it also plays a critical role in mitochondrial oxidative phosphorylation, energy metabolism, and the regulation of mitochondrial morphology and calcium uptake. Additionally, C1QBP functions as an RNA and protein chaperone in mitochondria and interacts with several viral, bacterial, and tumor-associated peptides. Dysfunction or dysregulation of C1QBP is implicated in cancer, inflammatory conditions, cardiovascular disease, and mitochondrial disorders.
LyP-1: selectively binds C1QBP, leading to tumor targeting and cytotoxicity in certain cancer models. No approved drugs/mechanisms established; mainly investigational
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP).